Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute Advancing Women's Health (InAWH) is an Austin-based global non-profit organization dedicated to closing the gap between scientific research and clinical practice in women's midlife health, specifically peri- and post-menopause. Launched in 2026 by private investment firm Factory Capital and founder Anna Samuelsson, InAWH focuses on building clinical infrastructure, including standardized treatment protocols, care pathways, and clinician training. By establishing these foundational frameworks, the institute aims to de-risk the sector and make women's midlife health a scalable, investable healthcare category. Led by CEO Paula Schneider, InAWH collaborates with a multidisciplinary medical advisory board of experts from institutions such as Yale, Oxford, and UNSW.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Advancing Women's Health.